Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chike Okocha"'
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 9 (2019)
Background: We aimed to assess the quality of physical health monitoring following rapid tranquillisation (RT) for acute behavioural disturbance in UK mental health services. Methods: The Prescribing Observatory for Mental Health (POMH-UK) initiated
Externí odkaz:
https://doaj.org/article/299be8cca5034a7fb84e43ad757fd6fa
Publikováno v:
Journal of Psychopharmacology (Oxford, England)
Background: A quality improvement programme addressing prescribing practice for acutely disturbed behaviour was initiated by the Prescribing Observatory for Mental Health. Method: This study analysed data from a baseline clinical audit conducted in i
Publikováno v:
Therapeutic Advances in Psychopharmacology
Therapeutic Advances in Psychopharmacology, Vol 9 (2019)
Therapeutic Advances in Psychopharmacology, Vol 9 (2019)
Background: We aimed to assess the quality of physical health monitoring following rapid tranquillisation (RT) for acute behavioural disturbance in UK mental health services. Methods: The Prescribing Observatory for Mental Health (POMH-UK) initiated
Autor:
Elias Tsakanikos, Chike Okocha, Symon Wandiembe, Harpreet Sanghara, Hanne Jakobsen, Eugenia Kravariti, Matthew Finch, Daniel Hayes, Hannah Sims
Publikováno v:
Psychiatric Services. 63:161-168
Forgetting is commonly stated as a reason for missing mental health appointments. The authors examined the effect of short message service (SMS), or text message, reminders on the attendance of appointments at four community mental health clinics in
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 12:210-214
Objective. It takes 6 weeks for plasma levels of risperidone long-acting injection (RLAI) to reach steady state, and randomised controlled trials demonstrate a flat dose-response curve. In clinical practice, the dose of RLAI is often increased rapidl
Publikováno v:
Journal of Psychopharmacology. 17:223-229
The development of atypical antipsychotics has not only given the prescriber more options, but also increased the complexity of decision making. We examined current prescribing practice for antipsychotic and anticholinergic drugs, which involved a 1-
Publikováno v:
Psychiatric Bulletin. 26:411-414
Aims and MethodA1-day census, involving 3576 psychiatric in-patients prescribed antipsychotic medication, was conducted as a prelude to a multi-centre audit. The aim was to explore the extent to which a number of patient variables explain antipsychot
Publikováno v:
Psychiatric Bulletin. 26:414-418
Aims and MethodForty-seven UK mental health services participated in a 1-day audit of prescribing of antipsychotic drugs. Audit standards were derived from national guidelines and consensus statements.ResultsOf the 3132 patients, 20% were prescribed
Publikováno v:
International journal of psychiatry in clinical practice. 12(4)
Midazolam is a benzodiazepine known to be effective as a treatment for status epilepticus and for rapid tranquillisation. Buccal midazolam has recently become available in the UK. We introduced it as a treatment option for rapid tranquillisation on o
Autor:
Carol Paton, Chike Okocha
Publikováno v:
Psychiatric Bulletin. 28:12-14
Aims and MethodRisperidone long-acting injection (RLAI) is the first atypical antipsychotic drug to be available in a ‘depot’ formulation. The evidence base underpinning its use is small. We sought to evaluate its early use in clinical practice b